116 related articles for article (PubMed ID: 29483676)
1. The second point mutation in PREPL: a case report and literature review.
Silva S; Miyake N; Tapia C; Matsumoto N
J Hum Genet; 2018 May; 63(5):677-681. PubMed ID: 29483676
[TBL] [Abstract][Full Text] [Related]
2. PREPL deficiency with or without cystinuria causes a novel myasthenic syndrome.
Régal L; Shen XM; Selcen D; Verhille C; Meulemans S; Creemers JW; Engel AG
Neurology; 2014 Apr; 82(14):1254-60. PubMed ID: 24610330
[TBL] [Abstract][Full Text] [Related]
3. PREPL Deficiency: A Homozygous Splice Site PREPL Mutation in a Patient With Congenital Myasthenic Syndrome and Absence of Ovaries and Hypoplasia of Uterus.
Yang Q; Hua R; Qian J; Yi S; Shen F; Zhang Q; Li M; Yi S; Luo J; Fan X
Front Genet; 2020; 11():198. PubMed ID: 32218803
[TBL] [Abstract][Full Text] [Related]
4. First maternal uniparental disomy for chromosome 2 with PREPL novel frameshift mutation of congenital myasthenic syndrome 22 in an infant.
Zhang P; Wu B; Lu Y; Ni Q; Liu R; Zhou W; Wang H
Mol Genet Genomic Med; 2020 Mar; 8(3):e1144. PubMed ID: 31985178
[TBL] [Abstract][Full Text] [Related]
5. PREPL deficiency: delineation of the phenotype and development of a functional blood assay.
Régal L; Mårtensson E; Maystadt I; Voermans N; Lederer D; Burlina A; Juan Fita MJ; Hoogeboom AJM; Olsson Engman M; Hollemans T; Schouten M; Meulemans S; Jonson T; François I; Gil Ortega D; Kamsteeg EJ; Creemers JWM
Genet Med; 2018 Jan; 20(1):109-118. PubMed ID: 28726805
[TBL] [Abstract][Full Text] [Related]
6. Isolated PREPL deficiency associated with congenital myasthenic syndrome-22.
Laugwitz L; Redler S; Buchert R; Sturm M; Zeile I; Schara U; Wieczorek D; Haack T; Distelmaier F
Klin Padiatr; 2018 Sep; 230(5):281-283. PubMed ID: 29913539
[No Abstract] [Full Text] [Related]
7. Further delineation of genotype-phenotype correlation in homozygous 2p21 deletion syndromes: first description of patients without cystinuria.
Bartholdi D; Asadollahi R; Oneda B; Schmitt-Mechelke T; Tonella P; Baumer A; Rauch A
Am J Med Genet A; 2013 Aug; 161A(8):1853-9. PubMed ID: 23794250
[TBL] [Abstract][Full Text] [Related]
8. PREPL, a prolyl endopeptidase-like enzyme by name only?--Lessons from patients.
Boonen K; Régal L; Jaeken J; Creemers JW
CNS Neurol Disord Drug Targets; 2011 May; 10(3):355-60. PubMed ID: 21222627
[TBL] [Abstract][Full Text] [Related]
9. Deletion of PREPL, a gene encoding a putative serine oligopeptidase, in patients with hypotonia-cystinuria syndrome.
Jaeken J; Martens K; Francois I; Eyskens F; Lecointre C; Derua R; Meulemans S; Slootstra JW; Waelkens E; de Zegher F; Creemers JW; Matthijs G
Am J Hum Genet; 2006 Jan; 78(1):38-51. PubMed ID: 16385448
[TBL] [Abstract][Full Text] [Related]
10. Prolyl Endopeptidase-like Deficiency Associated with Growth Hormone Deficiency.
Sayol-Torres L; Valenzuela MI; Tomasini R; Fernández-Alvarez P; Clemente M; Yeste D
J Clin Res Pediatr Endocrinol; 2023 May; 15(2):205-209. PubMed ID: 34693706
[TBL] [Abstract][Full Text] [Related]
11. The First Case of Congenital Myasthenic Syndrome Caused by a Large Homozygous Deletion in the C-Terminal Region of COLQ (Collagen Like Tail Subunit of Asymmetric Acetylcholinesterase) Protein.
Laforgia N; De Cosmo L; Palumbo O; Ranieri C; Sesta M; Capodiferro D; Pantaleo A; Iapicca P; Lastella P; Capozza M; Schettini F; Bukvic N; Bagnulo R; Resta N
Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33353066
[TBL] [Abstract][Full Text] [Related]
12. Clinical and molecular analysis of a novel COLQ missense mutation causing congenital myasthenic syndrome in a Syrian family.
Matlik HN; Milhem RM; Saadeldin IY; Al-Jaibeji HS; Al-Gazali L; Ali BR
Pediatr Neurol; 2014 Jul; 51(1):165-9. PubMed ID: 24938146
[TBL] [Abstract][Full Text] [Related]
13. Deletion of PREPl causes growth impairment and hypotonia in mice.
Lone AM; Leidl M; McFedries AK; Horner JW; Creemers J; Saghatelian A
PLoS One; 2014; 9(2):e89160. PubMed ID: 24586561
[TBL] [Abstract][Full Text] [Related]
14. Recessive VAMP1 mutations associated with severe congenital myasthenic syndromes - A recognizable clinical phenotype.
Polavarapu K; Vengalil S; Preethish-Kumar V; Arunachal G; Nashi S; Mohan D; Chawla T; Bardhan M; Nandeesh B; Gupta P; Gowda VK; Lochmüller H; Nalini A
Eur J Paediatr Neurol; 2021 Mar; 31():54-60. PubMed ID: 33631708
[TBL] [Abstract][Full Text] [Related]
15. Deletion of C2orf34, PREPL and SLC3A1 causes atypical hypotonia-cystinuria syndrome.
Chabrol B; Martens K; Meulemans S; Cano A; Jaeken J; Matthijs G; Creemers JW
J Med Genet; 2008 May; 45(5):314-8. PubMed ID: 18234729
[TBL] [Abstract][Full Text] [Related]
16. First cardiac manifestation of hypotonia-cystinuria syndrome.
Kılıç M; Ceylan AC; Örün UA; Kılıç E
Metab Brain Dis; 2018 Aug; 33(4):1375-1379. PubMed ID: 29627929
[TBL] [Abstract][Full Text] [Related]
17. Choline Acetyltransferase Mutations Causing Congenital Myasthenic Syndrome: Molecular Findings and Genotype-Phenotype Correlations.
Arredondo J; Lara M; Gospe SM; Mazia CG; Vaccarezza M; Garcia-Erro M; Bowe CM; Chang CH; Mezei MM; Maselli RA
Hum Mutat; 2015 Sep; 36(9):881-93. PubMed ID: 26080897
[TBL] [Abstract][Full Text] [Related]
18. A Family Case of Congenital Myasthenic Syndrome-22 Induced by Different Combinations of Molecular Causes in Siblings.
Shchagina O; Bessonova L; Bychkov I; Beskorovainaya T; Poliakov A
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32707643
[TBL] [Abstract][Full Text] [Related]
19. The unfolding landscape of the congenital myasthenic syndromes.
Engel AG; Shen XM; Selcen D
Ann N Y Acad Sci; 2018 Feb; 1413(1):25-34. PubMed ID: 29355968
[TBL] [Abstract][Full Text] [Related]
20. A substrate-free activity-based protein profiling screen for the discovery of selective PREPL inhibitors.
Lone AM; Bachovchin DA; Westwood DB; Speers AE; Spicer TP; Fernandez-Vega V; Chase P; Hodder PS; Rosen H; Cravatt BF; Saghatelian A
J Am Chem Soc; 2011 Aug; 133(30):11665-74. PubMed ID: 21692504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
